5943-04-4Relevant articles and documents
2,4-Disubstituted 5-Nitroimidazoles Potent against Clostridium difficile
Spitz, Cédric,Mathias, Fanny,Péchiné, Séverine,Doan, Tri Hanh Dung,Innocent, Jean,Pellissier, Sylvain,Di Giorgio, Carole,Crozet, Maxime D.,Janoir, Claire,Vanelle, Patrice
, p. 561 - 569 (2019)
Metronidazole is one of the first-line treatments for non-severe Clostridium difficile infections (CDI). However, resistance limits its use in cases of severe and complicated CDI. Structure–activity relationships previously described for the 5-nitroimidazole series have shown that functionalization at the 2- and 4-positions can impart better activity against parasites and anaerobic bacteria than metronidazole. Herein we report the synthesis of new 2,4-disubstituted 5-nitroimidazole compounds that show potent antibacterial activity against C. difficile. We used a vicarious nucleophilic substitution of hydrogen (VNS) reaction to introduce a phenylmethylsulfone at the 4-position and a unimolecular radical nucleophilic substitution (SRN1) reaction to introduce an ethylenic function at the 2-position of the 5-nitroimidazole scaffold.
Nucleophilicity Parameters of Arylsulfonyl-Substituted Halomethyl Anions
Li, Zhen,Chen, Quan,Mayer, Peter,Mayr, Herbert
, p. 2011 - 2017 (2017)
The rates of the reactions of the arylsulfonyl-substituted carbanions carrying α-chloro and α-bromo substituents (1a-e) with quinone methides 2a-g and benzylidenemalonates 2h and 2i in DMSO were determined photometrically at 20 °C. The reactions were perf
New synthetic sulfone derivatives inhibit growth, adhesion and the leucine arylamidase APE2 gene expression of Candida albicans in vitro
Staniszewska, Monika,Bondaryk, Ma?gorzata,Ochal, Zbigniew
, p. 314 - 321 (2015/03/04)
The successful preventing and effective treatment of invasive Candida albicans infections required research focused on synthesis of new classes of agents and antifungal activity studies. Bromodichloromethyl-4-chloro-3-nitrophenyl sulfone (named compound 6); dichloromethyl-4-chloro-3-nitrophenyl sulfone (named 7); and chlorodibromomethyl-4-hydrazino-3-nitrophenyl sulfone (named 11) on inhibition of planktonic cells' growth, leucine arylamidase APE2 gene expression, and adhesion to epithelial cells were investigated. In vitro anti-Candida activities were determined against wild-types, and the morphogenesis mutants: Δefg1 and Δcph1. MICs of compounds 6, 7 and 11 (concentrated at 0.25-16 μg/ml) were determined using the Clinical and Laboratory Standards Institute Broth Microdilution Method (M27-A3 Document). APE2 expression was analyzed using RT-PCR; relative quantification was normalized against ACT1 in cells growth in YEPD and on Caco-2 cell line. Adherence assay of C. albicans to Caco-2 was performed in 24-well-plate. The structure activity relationship suggested that sulfone containing hydrazine function at C-1 (compound 11) showed higher antifungal activity (cell inhibition% = 100 at 1-16 μg/ml) than the remaining sulfones with chlorine at C-1. Δcph1/Δefg1 was highly sensitive to compound 11, while the sensitivity was reduced in Δcph1/Δefg1::EFG1 (% = 100 at 16-fold higher concentration). Compound 11 significantly affected adherence to epithelium (P ≤0.05) and hyphae formation. The APE2 up-regulation plays role in sulfones' resistance on MAP kinase pathway. Either CPH1 or EFG1 play a role in the resistance mechanism in sulfones. The strain-dependent phenomenon is a factor in the sulfone resistance mechanism. Sulfones' mode of action was attributed to reduced virulence arsenal in terms of adhesiveness and pathogenic potential related to the APE2 expression and morphogenesis.
Lowering of 5-nitroimidazole's mutagenicity: Towards optimal antiparasitic pharmacophore
Crozet, Maxime D.,Botta, Celine,Gasquet, Monique,Curti, Christophe,Remusat, Vincent,Hutter, Sebastien,Chapelle, Olivier,Azas, Nadine,De Meo, Michel,Vanelle, Patrice
scheme or table, p. 653 - 659 (2009/09/08)
To improve the antiparasitic pharmacophore, 20 5-nitroimidazoles bearing an arylsulfonylmethyl group were prepared from commercial imidazoles. The antiparasitic activity of these molecules was assessed against Trichomonas vaginalis, the in vitro cytotoxicity was evaluated on human monocytes and the mutagenicity was determined by the Salmonella mutagenicity assay. All IC50 on T. vaginalis were below the one of metronidazole. The determination of the specificity indexes (SIs), defined as the ratios of the cytotoxic activity and the antitrichomonas activity, indicated that 11 derivatives had a SI over the one of metronidazole. Molecules, bearing an additional methyl group on the 2-position, showed a lower mutagenicity than metronidazole. Moreover, three derivatives were characterized by a low mutagenicity and an efficient antitrichomonas activity.
Evaluation of electrophilic activities of substituted nitroarenes in the VNS reaction with secondary and tertiary carbanions
Blazej,Wilenska,Voynova,Makosza
, p. 2017 - 2030 (2008/12/23)
Relative electrophilic activities of substituted nitroarenes in the vicarious nucleophilic substitution (VNS) reaction with carbanion of chloromethylp-chlorophenyl and bromomethyl phenyl sulfones, 1 and 2, were determined via competitive experiments. The results are in good agreement with relative activities determined earlier in the competitive experiments with carbanion of chloromethyl phenyl sulfone 3 confirming reliability of these data. On the other hand, analogous competitive experiments with tertiary carbanions of chloroform and 1-chloroethyl phenyl sulfone gave results much affected by steric effects thus the VNS reaction with these carbanions cannot be used for evaluation of electrophilic activities of nitroarenes.
Rapid synthesis of new 5-nitroimidazoles as potential antibacterial drugs via VNS procedure
Crozet, Maxime D.,Remusat, Vincent,Curti, Christophe,Vanelle, Patrice
, p. 3639 - 3646 (2007/10/03)
Original 4-arylsulfonylmethyl-5-nitroimidazoles were prepared by reacting four chloromethylaryl sulfones with 5-nitroimidazole derivatives via a vicarious nucleophilic substitution (VNS) of hydrogen reaction. Copyright Taylor & Francis Group, LLC.
